 Jesus Delgado-Calle
Concepts (192)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteocytes | 22 | 2025 | 226 | 6.090 |
Why?
| | Bone Morphogenetic Proteins | 10 | 2020 | 67 | 3.100 |
Why?
| | Bone and Bones | 13 | 2025 | 494 | 3.020 |
Why?
| | Signal Transduction | 13 | 2024 | 1704 | 2.510 |
Why?
| | Osteoclasts | 11 | 2025 | 428 | 2.480 |
Why?
| | Bone Neoplasms | 4 | 2025 | 185 | 2.480 |
Why?
| | Bone Resorption | 11 | 2024 | 302 | 2.330 |
Why?
| | Multiple Myeloma | 11 | 2024 | 3050 | 2.320 |
Why?
| | Cell Communication | 5 | 2025 | 72 | 2.310 |
Why?
| | RANK Ligand | 8 | 2024 | 187 | 2.100 |
Why?
| | Osteogenesis | 11 | 2023 | 366 | 2.020 |
Why?
| | Bone Diseases | 4 | 2023 | 94 | 1.990 |
Why?
| | Receptors, Notch | 3 | 2022 | 28 | 1.900 |
Why?
| | Parathyroid Hormone | 5 | 2022 | 150 | 1.880 |
Why?
| | Osteoblasts | 11 | 2025 | 475 | 1.540 |
Why?
| | Bone Remodeling | 5 | 2021 | 154 | 1.400 |
Why?
| | DNA Methylation | 10 | 2016 | 583 | 1.280 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 252 | 1.190 |
Why?
| | Cell Line, Tumor | 11 | 2025 | 1423 | 1.180 |
Why?
| | Mice | 23 | 2025 | 5939 | 1.150 |
Why?
| | Animals | 29 | 2025 | 13464 | 1.110 |
Why?
| | Bone Marrow Cells | 5 | 2025 | 190 | 1.070 |
Why?
| | Genetic Markers | 9 | 2020 | 108 | 1.050 |
Why?
| | Osteolysis | 3 | 2022 | 75 | 1.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 11 | 2020 | 200 | 1.000 |
Why?
| | Osteoporosis | 5 | 2016 | 162 | 0.990 |
Why?
| | Chemokine CCL3 | 1 | 2024 | 13 | 0.900 |
Why?
| | HMGB1 Protein | 1 | 2024 | 21 | 0.900 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 73 | 0.870 |
Why?
| | Chemokine CXCL12 | 1 | 2024 | 34 | 0.860 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2024 | 853 | 0.840 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 3 | 2022 | 25 | 0.830 |
Why?
| | Epigenesis, Genetic | 5 | 2016 | 403 | 0.780 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 327 | 0.740 |
Why?
| | Azacitidine | 5 | 2016 | 39 | 0.730 |
Why?
| | Wnt Signaling Pathway | 6 | 2023 | 95 | 0.680 |
Why?
| | Humans | 41 | 2025 | 52546 | 0.670 |
Why?
| | Osteoporotic Fractures | 3 | 2014 | 11 | 0.610 |
Why?
| | Gene Deletion | 2 | 2017 | 275 | 0.610 |
Why?
| | Osteitis Deformans | 3 | 2024 | 4 | 0.590 |
Why?
| | Down-Regulation | 3 | 2016 | 344 | 0.580 |
Why?
| | Adipocytes | 3 | 2025 | 130 | 0.580 |
Why?
| | Bone Marrow | 2 | 2020 | 363 | 0.570 |
Why?
| | Hip Fractures | 3 | 2014 | 47 | 0.560 |
Why?
| | Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.560 |
Why?
| | Adipogenesis | 3 | 2017 | 49 | 0.560 |
Why?
| | Gene Expression Regulation | 3 | 2014 | 1004 | 0.550 |
Why?
| | Breast Neoplasms | 2 | 2024 | 1206 | 0.550 |
Why?
| | Osteoarthritis, Hip | 2 | 2013 | 28 | 0.490 |
Why?
| | Osteoprotegerin | 3 | 2016 | 53 | 0.480 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 30 | 0.480 |
Why?
| | Cell Line | 6 | 2020 | 1030 | 0.450 |
Why?
| | Stress, Mechanical | 1 | 2013 | 95 | 0.410 |
Why?
| | Disease Progression | 3 | 2021 | 872 | 0.390 |
Why?
| | Neoplasms | 2 | 2025 | 1305 | 0.380 |
Why?
| | Nitric Oxide | 1 | 2013 | 244 | 0.370 |
Why?
| | Hyperostosis | 2 | 2022 | 4 | 0.360 |
Why?
| | Mice, Knockout | 4 | 2018 | 909 | 0.350 |
Why?
| | Cell Lineage | 1 | 2011 | 88 | 0.350 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 92 | 0.340 |
Why?
| | Fractures, Bone | 1 | 2012 | 106 | 0.340 |
Why?
| | Disease Models, Animal | 6 | 2024 | 1480 | 0.340 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 181 | 0.320 |
Why?
| | beta Catenin | 3 | 2022 | 103 | 0.310 |
Why?
| | CpG Islands | 4 | 2016 | 115 | 0.300 |
Why?
| | Cell Differentiation | 7 | 2023 | 673 | 0.300 |
Why?
| | Gene Expression Profiling | 3 | 2024 | 1108 | 0.290 |
Why?
| | Models, Biological | 2 | 2025 | 739 | 0.280 |
Why?
| | Organ Culture Techniques | 2 | 2025 | 44 | 0.250 |
Why?
| | Fibroblast Growth Factors | 2 | 2020 | 49 | 0.250 |
Why?
| | Glycoproteins | 2 | 2016 | 122 | 0.240 |
Why?
| | Mice, Inbred C57BL | 3 | 2022 | 1898 | 0.240 |
Why?
| | Female | 12 | 2024 | 28214 | 0.230 |
Why?
| | Aged, 80 and over | 7 | 2016 | 3414 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 217 | 0.220 |
Why?
| | Weight-Bearing | 2 | 2016 | 45 | 0.220 |
Why?
| | Transcriptome | 2 | 2024 | 367 | 0.210 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2024 | 143 | 0.210 |
Why?
| | Coculture Techniques | 2 | 2025 | 143 | 0.200 |
Why?
| | DNA, Circular | 1 | 2022 | 18 | 0.200 |
Why?
| | Wnt Proteins | 1 | 2023 | 102 | 0.190 |
Why?
| | Genome | 1 | 2022 | 62 | 0.190 |
Why?
| | Clodronic Acid | 1 | 2021 | 19 | 0.180 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 79 | 0.180 |
Why?
| | Gene Expression | 4 | 2023 | 623 | 0.180 |
Why?
| | Transcription, Genetic | 2 | 2013 | 379 | 0.170 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2016 | 106 | 0.170 |
Why?
| | Bone Density Conservation Agents | 1 | 2021 | 75 | 0.170 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 770 | 0.170 |
Why?
| | Proteomics | 1 | 2023 | 327 | 0.170 |
Why?
| | Aging | 2 | 2016 | 709 | 0.170 |
Why?
| | Neoplasm Invasiveness | 1 | 2021 | 277 | 0.160 |
Why?
| | Cells, Cultured | 4 | 2018 | 1586 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 187 | 0.160 |
Why?
| | Aged | 8 | 2016 | 10200 | 0.160 |
Why?
| | Neovascularization, Pathologic | 1 | 2020 | 158 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2021 | 1372 | 0.140 |
Why?
| | Mice, Transgenic | 4 | 2023 | 563 | 0.130 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 111 | 0.130 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 133 | 0.130 |
Why?
| | DNA | 2 | 2022 | 548 | 0.130 |
Why?
| | 5-Methylcytosine | 1 | 2016 | 16 | 0.130 |
Why?
| | Extracellular Matrix Proteins | 1 | 2016 | 69 | 0.130 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 237 | 0.120 |
Why?
| | Organ Size | 1 | 2016 | 231 | 0.120 |
Why?
| | Lipids | 1 | 2017 | 160 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2016 | 1024 | 0.120 |
Why?
| | Apoptosis | 2 | 2024 | 1121 | 0.120 |
Why?
| | Stromal Cells | 2 | 2019 | 77 | 0.120 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 230 | 0.120 |
Why?
| | Calcification, Physiologic | 2 | 2016 | 42 | 0.120 |
Why?
| | Cell Survival | 1 | 2017 | 600 | 0.120 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2014 | 412 | 0.110 |
Why?
| | Dexamethasone | 1 | 2017 | 439 | 0.110 |
Why?
| | Receptors, Parathyroid Hormone | 1 | 2014 | 9 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2016 | 238 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2016 | 395 | 0.110 |
Why?
| | Pulsatile Flow | 1 | 2013 | 18 | 0.110 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 48 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 1217 | 0.100 |
Why?
| | Promoter Regions, Genetic | 2 | 2014 | 474 | 0.100 |
Why?
| | Stem Cells | 1 | 2014 | 182 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 478 | 0.100 |
Why?
| | DNA Modification Methylases | 1 | 2013 | 28 | 0.100 |
Why?
| | Transfection | 1 | 2013 | 369 | 0.100 |
Why?
| | Up-Regulation | 1 | 2014 | 462 | 0.100 |
Why?
| | Hallux Valgus | 1 | 2012 | 3 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 186 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2012 | 72 | 0.090 |
Why?
| | Cloning, Molecular | 1 | 2012 | 181 | 0.090 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2012 | 48 | 0.090 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 184 | 0.090 |
Why?
| | PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2011 | 1 | 0.090 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2011 | 33 | 0.090 |
Why?
| | Cytokines | 1 | 2014 | 624 | 0.090 |
Why?
| | Laser Capture Microdissection | 1 | 2011 | 6 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2012 | 231 | 0.090 |
Why?
| | Cell Count | 1 | 2011 | 144 | 0.090 |
Why?
| | Calibration | 1 | 2011 | 57 | 0.090 |
Why?
| | Blood Proteins | 1 | 2011 | 84 | 0.090 |
Why?
| | MicroRNAs | 1 | 2014 | 385 | 0.080 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 34 | 0.080 |
Why?
| | Transcription Factor AP-1 | 1 | 2010 | 62 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2012 | 246 | 0.080 |
Why?
| | Protein Binding | 1 | 2012 | 670 | 0.080 |
Why?
| | Base Sequence | 1 | 2011 | 634 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 459 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2011 | 980 | 0.070 |
Why?
| | Proteins | 1 | 2011 | 353 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 50 | 0.070 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 40 | 0.070 |
Why?
| | Cohort Studies | 1 | 2011 | 1552 | 0.070 |
Why?
| | Male | 5 | 2014 | 26808 | 0.060 |
Why?
| | Primary Cell Culture | 2 | 2019 | 62 | 0.060 |
Why?
| | Chromatin | 2 | 2016 | 141 | 0.060 |
Why?
| | Cell Culture Techniques | 1 | 2025 | 99 | 0.050 |
Why?
| | Middle Aged | 3 | 2016 | 13091 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2024 | 104 | 0.050 |
Why?
| | Eukaryotic Cells | 1 | 2022 | 15 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 136 | 0.050 |
Why?
| | Bone Density | 2 | 2015 | 398 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2020 | 3 | 0.040 |
Why?
| | Bombyx | 1 | 2019 | 2 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2019 | 74 | 0.040 |
Why?
| | Phenotype | 1 | 2020 | 800 | 0.030 |
Why?
| | Child, Preschool | 2 | 2016 | 4034 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2016 | 57 | 0.030 |
Why?
| | Calcitriol | 1 | 2016 | 39 | 0.030 |
Why?
| | Osteocalcin | 1 | 2016 | 45 | 0.030 |
Why?
| | Genome, Human | 1 | 2016 | 121 | 0.030 |
Why?
| | Mice, Nude | 1 | 2016 | 231 | 0.030 |
Why?
| | Young Adult | 2 | 2016 | 4329 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2014 | 16 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Genomics | 1 | 2016 | 270 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 119 | 0.030 |
Why?
| | Adolescent | 2 | 2016 | 6713 | 0.030 |
Why?
| | Osteosarcoma | 1 | 2014 | 44 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2014 | 147 | 0.030 |
Why?
| | Gene Frequency | 1 | 2013 | 99 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 151 | 0.030 |
Why?
| | Bone Lengthening | 1 | 2012 | 5 | 0.020 |
Why?
| | Child | 2 | 2016 | 7194 | 0.020 |
Why?
| | Histones | 1 | 2014 | 316 | 0.020 |
Why?
| | Orthopedic Procedures | 1 | 2012 | 71 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 507 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 400 | 0.020 |
Why?
| | Quality of Life | 1 | 2014 | 882 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 49 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 186 | 0.020 |
Why?
| | Cell Movement | 1 | 2008 | 273 | 0.020 |
Why?
| | Adult | 1 | 2016 | 14168 | 0.010 |
Why?
|
|
Delgado-Calle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|